Ишемическая болезнь сердца у женщин: особенности диагностики и лечения. Государственное учреждение «Институт терапии им. Л. Т. Малой UAMS»
Аннотация
В настоящем обзоре суммированы данные современной литературы, касающиеся особенностей ишемической болезни сердца у женщин. Особенности диагностики и лечения заболевания рассмотрены с позиций гендерной медицины. Представлена не только теоретическая
информация, но и возможности ее клинического применения.
Об авторах
В. И. Волков
АМН Украины
Украина
Украина
Владимир Иванович Волков, д-р мед. наук, зав. отделом
ДУ «Институт терапии им. Л. Т. Малой АМН Украины»
отдел Атеросклероза и ИБС
61039
просп. Постылева, 2а
Харьков
А. С. Исаева
АМН Украины
Украина
Украина
Анна Сергеевна Исаева, канд. мед. наук, с. н. с.
ДУ «Институт терапии им. Л. Т. Малой АМН Украины»
отдел Атеросклероза и ИБС
61039
просп. Постылева, 2а
Харьков
Список литературы
1. Bellasi A., Raggi P., Merz C. N. B. et al. New insights into ischemic heart disease in women // Cleveland Clinic Journal of Medicine. 2007. August. Vol. 74, N 8. P. 585–594.
2. Fox A. A., Nussmeier N. A. Coronary artery bypass graft surgery in women // J. Cardiothorac. Vasc. Anesth. 2004. Vol. 18. P. 344–352.
3. Mosca L. Heart Disease Prevention in Women // Circulation. 2004. Vol. 109. P. e158–e160
4. Heras M. Ischemic Heart Disease in Women: Clinical Presentation, Non-Invasive Testing and Management of Acute Coronary Syndromes // Rev. Esp. Cardiol. 2006. Vol. 59. P. 371–381.
5. Stramba-Badiale M., Priori S. G. Gender-specific prescription for cardiovascular diseases? // Eur. Heart J. 2005. Vol. 26 (16). Р. 1571–1572.
6. Hemingway H., Langenberg C., Damant J. Prevalence of Angina in Women Versus Men A Systematic Review and Meta-Analysis of International Variations Across 31 Countries // Circulation. 2008. Vol. 117. P. 1526–1536.
7. McSweeney J. C., Cody M., O’Sullivan P. et al. Women’s early warning symptoms of acute myocardial infarction // Circulation. 2003. Vol. 108. P. 2619–2623.
8. Fox K. F. Investigation and management of chest pain // Heart. 2005. Vol. 91. P. 105–110
9. Johnson B. D., Shaw L. J., Pepine C. J. et al. Pain predicts cardiovascular events in women without obstruc tive coronary artery disease: results from the NIH-NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE) study // Eur. Heart J. 2006. Vol. 27. P. 1408–1415.
10. Richards H. M., Reid M. E., Murray Watt G. C. Socio-economic variations in responses to chest pain: qualitative study // BMJ. 2002. June 1. Vol. 324 (7349). P. 1308.
11. Chaturvedi N., Rai H., Ben-Shlomo Y. Lay diagnosis and health-care-seeking behavior for chest pain in South Asians and Europeans // Lancet. 1997. Vol. 350. P. 1578–1583.
12. D’Antonio B., Dupuis G., Fleet R. et al. Sex differences in chest pain and prediction of exercise induced ischemia // Ca J. Cardiol. 2003. Vol. 19. P. 515–522.
13. Espinola-Klein C., Rupprecht H. J., Erbel R. et al. Tenyear outcome after coronary angioplasty in patients with single-vessel coronary artery disease and comparison with the results of the Coronary Artery Surgery Study (CASS) // Am. J. Cardiol. 2000. Vol. 85 (3). P. 321–326.
14. Kaski J. C. Cardiac syndrome in women: the role of estrogen deficiency // Heart. 2006. Vol. 92 (Supll III). P. iii5-iii9
15. Lerman A., Sopko G. Women and Cardiovascular Heart Disease: Clinical Implications From the Women’s Ischemia Syndrome Evaluation (WISE) Study: Are We Smarter? // J. Am. Coll. Cardiol. 2006. Vol. 47. P. S59–S62.
16. Douglas P. S., Ginsburg G. S. The Evaluation of Chest Pain in Women // New Engl. J. Med. 1996. Vol. 334. P. 1311–1315.
17. Zaman J. M., Junghans C., Sekhri N. et al. Presentation of stable angina pectoris among women and South Asian people // CMAJ. 2008. September 20. Vol. 179 (7). P. 659–667.
18. Milner K. A., Funk M., Amold A. et al. Typical symptoms are predictive of acute coronary syndromes in women // Am. Heart J. 2002. Vol. 143. P. 283–288.
19. Bugiardini R., Estrada J. L., Nikus K. et al. Gender bias in acute coronary syndromes // Curr. Vasc. Pharmacol. 2010. Mar. Vol. 8 (2). P. 276–284.
20. Stangl V., Witzel V., Baumann G. et al. Current diagnostic concepts to detect coronary artery disease in women // Eur. Heart J. 2008. Vol. 29 (6). P. 707–717.
21. Detry J. M., Kapita B. M., Cosyns J. et al. Diagnostic value of history and maximal exercise electrocardiography in men and women suspected of coronary heart disease // Circulation. 1977. Nov. Vol. 56(5). P. 756–761
22. Clark P., Glasser S. P., Lyman G. H. et al. Relation of results of exercise stress tests in young women to phases of the menstrual cycle // Am. J. Cardiology. 1988. Vol. 61. Issue 1. P. 197–199.
23. Lloyd G. W., Patel N. R., McGing E. et al. Does angina vary with the menstrual cycle in women with premenopausal coronary artery disease? // Heart. 2000. Vol. 84. P. 189–192.
24. Skafar D. F., Rui X., Morales J. et al. Female Sex Hormones and Cardiovascular Disease in Women // J. Clin. Endocrin. Metab. 1997. Vol. 82, N 12. P. 3913–3918.
25. Stoletniy L. N., Pai R. G. Value of QT Dispersion in the Interpretation of Exercise Stress Test in Women // Circulation. 1997. Vol. 96. P. 904–910.
26. Alexander K. P. et al. Value of exercise treadmill testing in women // J. Am. Coll. Cardiol. 1998. Vol. 32. P. 1657–1664.
27. Kwok Y. S., Kim C., Grady D. et al. Meta-analysis of exercise testing to detect coronary artery disease in women // Am. J. Cardiology. 1999. Vol. 83. P. 660–666.
28. Dhond M. R., Nguyen T., Whitley T. B. et al. Prognostic Value of 12-Lead Electrocardiogram During Dobutamine Stress Echocardiography // Echocardiography. 2000. Vol. 17, Issue 5. P. 429–432.
29. Kim C., Kwok Y. S., P. Redberg H. R. Pharmacologic stress testing for coronary disease diagnosis: a meta-analysis // Am. Heart J. 2001. Vol. 142. P. 934–944.
30. Schannwell C. M., Lazica D., Plehn G. et al. The current status of noninvasive cardiac diagnosis in women with suspected coronary heart disease // Med. Klin. (Munich). 2002. Sep. Vol. 15, N 97 (9). P. 513–521.
31. Masini M., Picano E., Lattanzi F. et al. High dose dipyridamole-echocardiography test in women: correlation with exercise-electrocardiography test and coronary arteriography // J. Am. Coll. Cardiol. 1988. Vol. 12. P. 682–685.
32. Cortigiani L., Dodi C., Paolini E. A. et al. Prognostic value of pharmacological stress echocardiography in women with chest pain and unknown coronary artery disease // J. Am. Coll. Cardiol. 1998. Vol. 32. P. 1975–1981.
33. Earnest C. P., Blair S. N., Church T. S. Age attenuated response to aerobic conditioning in postmenopausal women // Eur. J. Appl. Physiol. 2010. Sep. Vol. 110, 1. P. 75–82.
34. Chang C. J., Wu C. H., Yao W. J. et al. Relationships of age, menopause and central obesity on cardiovascular disease risk factors in Chinese women // Int. J. Obes. Relat. Metab. Disord. 2000. Dec. Vol. 24 (12). P. 1699–1704.
35. Guidelines of management of stable angina pectoris. Joint task force of the European society of cardiology // Eur. Heart J. 2006. Vol. 27. P. 1341–1381.
36. Stempfer M. J., Golditz G. A., Willet W. C. et al. Post menopausal estrogen therapy and cardiovascular disease. Ten year follw-up from the Nurses` Health Stu dy // New Engl. J. Med. 1991. Vol. 325. P. 752–762.
37. Schenk-Gustafsson K. Management of menopause in the context of coronary heart disease // Maturitas. 2011. Vol. 68. P. 94–97.
38. Burke J. H., Goldberger J. J., Ehlert F. A. et al. Gender differences in heart rate before and after autonomic blockade: evidence against an intrinsic gender effect // Am. J. Med. 1996. May. Vol. 100. (5). P. 24–28.
39. Vitale C., Iellamo F., Volterrani M. et al. Heart rate control in an unselected consecutive population of outpatients with stable coronary artery disease: Analysis of the CARDIf Study Cohort // Angiology. 2010. Nov. Vol. 61(8). P. 763–767.
40. Wu Q., Zhao Z., Sun H. et al. Oestrogen changed cardiomyocyte contraction and beta-adrenoceptor expression in rat hearts subjected to ischaemia-reperfusion // Exp. Physiol. 2008. Sep. Vol. 93(9). P. 1034–1043.
41. Luzier A. B., Killian A., Wilton J. H. et al. Gender-related effects on metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers // Clin. Pharmacol. Ther. 1999. Dec. Vol. 66 (6). P. 594–601.
42. Martin R. M., Biswas P. N., Freemantle S. N. Age and sex distribution of suspected adverse drug reactions to newly marketed drugs in general practice in England: analysis of 48 cohort studies // Br. J. Clin. Pharmacol. 1998. Vol. 46 (5). P. 5–11.
43. King L. T., Brucker M. C. Pharmacology for women health. Health & Fitness, 2009. 1244 p.
44. Johnson J. A., Akers W. S., Herring V. L. et al. Gender Differences in Labetalol Kinetics: Importance of Determining Stereoisomer Kinetics for Racemic Drugs // Pharmacotherapy. 2000. Vol. 20 (6). P. 622–628.
45. Olsson G., Wikstrand J., Warnold I. et al. Metoprololinduced reduction in postinfarction mortality: pooled results from five double-blind randomized trials // Eur. Heart J. 1992. Vol. 13, Issue 1. P. 28–32.
46. Bonnet N., Gadois C., McCloskey E. et al. Protective effect of beta blockers in postmenopausal women: influence on fractures, bone density, micro and macroarchitecture // Bone. 2007. May. Vol. 40 (5). P. 1209–1216.
47. Lahoza C., Mantillab T., Taboadac M. et al. Gender differences in evidence-based pharmacological therapy for patients with stable coronary heart disease // Cardiology. 2009. Vol. 133, Issue 3. P. 336–340.
48. http://clinicaltrials.gov/ct2/show/NCT01161823?term=postmenopausal+beta-blockers&rank=2.
49. Hsi D. H., Roshandel A., Singh N. et al. Headache response to glyceryl trinitrate in patients with and with-out obstructive coronary artery disease // Heart. 2005. Vol. 91 (9). P. 1164–1166.
50. Nabhan A. F., Rabie N. H. Isosorbide mononitrate versus alendronate for postmenopausal osteoporosis // Int. J. Gynaecol. Obstet. 2008. Dec. Vol. 103 (3). P. 213–216.
51. Jamal S. A., Cummings S. R., Hawker G. A. Isosorbide mononitrate increases bone formation and decreases bone resorption in postmenopausal women: a randomized trial // J. Bone Miner. Res. 2004. Sep. Vol. 19 (9). P. 1512–1517.
52. Nabhan A. F. A randomized clinical trial of the effects of isosorbide mononitrate on bone formation and resorption in post-menopausal women: a pilot study // Hum. Reprod. 2006. May. Vol. 21 (5). P. 1320–1324.
53. Nabhan A. F., Rabie N. H. Isosorbide mononitrate versus alendronate for postmenopausal osteoporosis // Int. J. Gynaecol. Obstet. 2008. Dec. Vol. 103 (3). P. 213–216.
54. Pouwels S., Lalmohamed A., van Staa T. et al. Use of organic nitrates and the risk of hip fracture: a population-based case-control study // J. Clin. Endocrinol. Metab. 2010. Apr. Vol. 95 (4). P. 1924–1931.
55. Dzhanashiia P. Kh., Zhiliaev E. V., Glazunov A. V. et al. The antianginal efficacy of calcium antagonists in men and women at 60 and older. Approaches to predicting the effect of the preparations // Ter. Arkh. 1994. Vol. 66 (10). P. 75–79.
56. Dominguez-Rodriguez A., Fard S. S., Abreu-Gonzalez P. et al. Randomised, double-blind, placebo-controlled trial of ivabradine in patients with acute coronary syndrome: effects of the If current inhibitor ivabradine on reduction of inflammation markers in patients with acute coronary syndrome–RIVIERA trial study design and rationale // Cardiovasc. Drugs. Ther. 2009. Jun. Vol. 23 (3). P. 243–247.
57. Ridker P. V. et al. A randomized trial of low dose aspirin in the primary prevention of cardiovascular disease in women // New Eng. J. Med. 2005. Vol. 325 (13). P. 1293–1304.
58. Cavallari L. H. Sex Difference in the Antiplatelet Effect of Aspirin in Patients with Stroke // The Annals of Pharmacotherapy. 2005. Vol. 40, N 5. P. 812–817.
59. Berger J. S., Bhatt D. L., Cannon C. P. et al. The Relative Safety and Efficacy of Clopidogrel in Women and Men: Meta-Analysis of 79, 613 Patients Enrolled in CREDO, CURE, CLARITY-TIMI 28, COMMIT, and CHARISMA // Circulation. 2007. Vol. 116 (II). P. 483–489.
60. Bandyopadhyay S., Bayer A. J., O’Mahony M. S. Age and gender bias in statin trials // QJM: An International Journal of Medicine. 2001. Vol. 94. P. 127–132.
61. Luzier A. B., Killian A., Wilton J. H. et al. Genderre lated effects on metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers// Clin. Pharmacol. Ther. 1999. Dec. Vol. 66 (6). P. 594–601.
62. Eisenberg T., Wells M. T. Statins and adverse cardiovascular events in moderate-risk females: a statistical and legal analysis with implications for FDA preemption claims // J. Empirical. Legal. Stud. 2008. Vol. 5. P. 507–550.
63. Grady D., Chaput L., Kristof M. Results of systematic review of research on diagnosis and treatment of coronary heart disease in women. Evidence Report / Technology Assessment No. 80 // AHRQ Publication. 2003. May. N 03–0035.
64. Petretta M., Costanzo P., Perrone-Filardi P., Chiariello M. Impact of gender in primary prevention of coronary heart disease with statin therapy: a meta-analysis // Int. J. Cardiol. 2008. Vol. 3. P. 23–28.
65. Walsh J. M., Pignone M. Drug treatment of hyperlipidemia in women // JAMA. 2004. Vol. 291. P. 2243–2252.
66. Sever P. S., Poulter N. R., Dahlöf B. et al. the ASCOT investigators: Reduction in cardiovascular events with atorvastatin in 2,532 patients with Type 2 diabetes // Diabetes Care. 2005. Vol. 28. P. 1151–1157.
67. Abramson J., Wright J. M. Are Statins Useful in Women and Older People? // The Lancet. 2008. Vol. 369, Issue 9557. P. 168–169.
68. Ridker P. M., Danielson E., Francisco A. H. Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein // New Eng. J. Med. 2008. Vol. 21, November 20, Vol. 359. P. 2195–2207.
69. Hague W., Forder P., Simes J. et al. Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study // Am. Heart J. 2003. Apr. Vol. 145 (4). P. 643–651.
70. LaRosa J. C., He J., Vupputuri S. Effect of Statins on Risk of Coronary Disease. A Meta-analysis of Randomized Controlled Trials // JAMA. 1999. Vol. 282. P. 2340–2346.
71. Wilt T. J., Bloomfield H. E., MacDonald et al. Effectiveness of Statin Therapy in Adults With Coronary Heart Disease // Arch. Intern. Med. 2004. Vol. 164. P. 1427–1436.
72. Sacks F. M., Pfeffer M. A., Moye L. A. et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators // New Engl. J. Med. 1996. Oct. 3. Vol. 335 (14). P. 1001–1009.
73. Karp I., Chen S. F., Pilote L. Sex differences in the effectiveness of statins after myocardial infarction // CMAJ. 2007. Jan. Vol. 30, N 176 (3). P. 1503–1507.
74. Dale K. M., Coleman C. I., Shah S. A. et al. Impact of gender on statin efficacy // Curr. Med. Res. Opin. 2007. Mar. Vol. 23 (3). P. 565–574.
75. Enriquez J. R., Pratap P., Zbilut J.P. et al. Women tolerate drug therapy for coronary artery disease as well as men do, but are treated less frequently with aspirin, beta-blockers, or statins // Gend. Med. 2008. Mar. Vol. 5 (1). P. 53–61.
76. Lahoz C., Mantilla T., Taboada M. et al. Gender differences in evidence-based pharmacological therapy for patients with stable coronary heart disease// Int. J. Cardiol. 2008. May 15. [Epub ahead of print]
77. Barrett-Connor E., Goodman-Gruen D. Prospective study of endogenous sex hormones and fatal cardiovascular disease in postmenopausal women // BMJ. 1995. Vol. 311. P. 1193–1196.
78. Cauley J. A., Gutai J. P., Glynn N. W. et al. Serum estrone concentrations and coronary artery disease in postmenopausal women // Arterioscler. Thromb. Vasc. Biol. 1994. Vol. 14. P. 14–18.
79. Clarkson T. B. Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression // Menopause. 2007. May-Jun. Vol. 14 (3), Pt 1. P. 373–384.
80. Domburg R. T., Klootwijk P., Decckers J. W. et al. The Cardiac Injury Score as a Predictor for Long Term Mortality in Survivors of Myocardial Infarction // Eur. Heart J. 1998. Vol. 19. P. 1034–1041.
Рецензия
Для цитирования:
Волков В.И., Исаева А.С. Ишемическая болезнь сердца у женщин: особенности диагностики и лечения. Государственное учреждение «Институт терапии им. Л. Т. Малой UAMS». Атеросклероз. 2011;7(1):45-59.
For citation:
Volkov V.I., Isayeva A.S. Diagnostic and treatment features of ischemic heart disease in women. «The institute of therapy named after L. T. Maloy of UAMS». Ateroscleroz. 2011;7(1):45-59. (In Russ.)
Просмотров:
185
Послать статью по эл. почте 